172 related articles for article (PubMed ID: 23737345)
21. Chemical stabilization of a Delta9-tetrahydrocannabinol prodrug in polymeric matrix systems produced by a hot-melt method: role of microenvironment pH.
Munjal M; ElSohly MA; Repka MA
AAPS PharmSciTech; 2006 Sep; 7(3):71. PubMed ID: 17025251
[TBL] [Abstract][Full Text] [Related]
22. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
[TBL] [Abstract][Full Text] [Related]
23. Prodrugs and nanomicelles to overcome ocular barriers for drug penetration.
Gote V; Ansong M; Pal D
Expert Opin Drug Metab Toxicol; 2020 Oct; 16(10):885-906. PubMed ID: 32729364
[TBL] [Abstract][Full Text] [Related]
24. Effect of mono- and di-acylation on the ocular disposition of ganciclovir: physicochemical properties, ocular bioreversion, and antiviral activity of short chain ester prodrugs.
Dias CS; Anand BS; Mitra AK
J Pharm Sci; 2002 Mar; 91(3):660-8. PubMed ID: 11920751
[TBL] [Abstract][Full Text] [Related]
25. Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections.
Katragadda S; Gunda S; Hariharan S; Mitra AK
Int J Pharm; 2008 Jul; 359(1-2):15-24. PubMed ID: 18472234
[TBL] [Abstract][Full Text] [Related]
26. Nonpolymeric nanoassemblies for ocular administration of acyclovir: pharmacokinetic evaluation in rabbits.
Stella B; Arpicco S; Rocco F; Burgalassi S; Nicosia N; Tampucci S; Chetoni P; Cattel L
Eur J Pharm Biopharm; 2012 Jan; 80(1):39-45. PubMed ID: 22008147
[TBL] [Abstract][Full Text] [Related]
27. Topical delta 9-tetrahydrocannabinol and aqueous dynamics in glaucoma.
Merritt JC; Perry DD; Russell DN; Jones BF
J Clin Pharmacol; 1981; 21(S1):467S-471S. PubMed ID: 6271841
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in ocular drug delivery.
Achouri D; Alhanout K; Piccerelle P; Andrieu V
Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
[TBL] [Abstract][Full Text] [Related]
29. Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.
Klumpers LE; Beumer TL; van Hasselt JG; Lipplaa A; Karger LB; Kleinloog HD; Freijer JI; de Kam ML; van Gerven JM
Br J Clin Pharmacol; 2012 Jul; 74(1):42-53. PubMed ID: 22680341
[TBL] [Abstract][Full Text] [Related]
30. Corneal permeation of ganciclovir: mechanism of ganciclovir permeation enhancement by acyl ester prodrug design.
Tirucherai GS; Dias C; Mitra AK
J Ocul Pharmacol Ther; 2002 Dec; 18(6):535-48. PubMed ID: 12537680
[TBL] [Abstract][Full Text] [Related]
31. Dipeptide monoester ganciclovir prodrugs for treating HSV-1-induced corneal epithelial and stromal keratitis: in vitro and in vivo evaluations.
Majumdar S; Nashed YE; Patel K; Jain R; Itahashi M; Neumann DM; Hill JM; Mitra AK
J Ocul Pharmacol Ther; 2005 Dec; 21(6):463-74. PubMed ID: 16386088
[TBL] [Abstract][Full Text] [Related]
32. Ocular absorption behavior of palmitoyl tilisolol, an amphiphilic prodrug of tilisolol, for ocular drug delivery.
Kawakami S; Nishida K; Mukai T; Yamamura K; Kobayashi K; Sakaeda T; Nakamura J; Nakashima M; Sasaki H
J Pharm Sci; 2001 Dec; 90(12):2113-20. PubMed ID: 11745770
[TBL] [Abstract][Full Text] [Related]
33. Influence of ophthalmic formulations on sodium cromoglycate disposition in the albino rabbit eye.
Shrewsbury RP; Swarbrick J; Newton KS; Riggs LC
J Pharm Pharmacol; 1985 Sep; 37(9):614-7. PubMed ID: 2867180
[TBL] [Abstract][Full Text] [Related]
34. Ocular penetration of topical Delta9-tetrahydrocannabinol from rabbit corneal or cul-de-sac application site.
Green KE; Kearse CE
Curr Eye Res; 2000 Jul; 21(1):566-70. PubMed ID: 11035538
[TBL] [Abstract][Full Text] [Related]
35. Impact of mucoadhesive agent inclusion on the intraocular pressure lowering profile of Δ
Sweeney C; Dudhipala N; Thakkar R; Mehraj T; Marathe S; Gul W; ElSohly MA; Murphy B; Majumdar S
Int J Pharm; 2022 Mar; 616():121564. PubMed ID: 35151817
[TBL] [Abstract][Full Text] [Related]
36. Delivery of gatifloxacin using microemulsion as vehicle: formulation, evaluation, transcorneal permeation and aqueous humor drug determination.
Kalam MA; Alshamsan A; Aljuffali IA; Mishra AK; Sultana Y
Drug Deliv; 2016; 23(3):896-907. PubMed ID: 24865289
[TBL] [Abstract][Full Text] [Related]
37. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
[TBL] [Abstract][Full Text] [Related]
38. Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats.
Fukano Y; Kawazu K
Drug Metab Dispos; 2009 Aug; 37(8):1622-34. PubMed ID: 19477946
[TBL] [Abstract][Full Text] [Related]
39. Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study.
de Vries M; van Rijckevorsel DCM; Vissers KCP; Wilder-Smith OHG; van Goor H;
Clin Gastroenterol Hepatol; 2017 Jul; 15(7):1079-1086.e4. PubMed ID: 27720917
[TBL] [Abstract][Full Text] [Related]
40. Tolerance to hypothermic and antinoceptive effects of ∆9-tetrahydrocannabinol (THC) vapor inhalation in rats.
Nguyen JD; Grant Y; Kerr TM; Gutierrez A; Cole M; Taffe MA
Pharmacol Biochem Behav; 2018 Sep; 172():33-38. PubMed ID: 30031028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
